HomeAEQ • FRA
add
Aequus Pharmaceuticals Inc
Previous close
€0.00050
Year range
€0.00050 - €0.030
Market cap
663.17K CAD
Avg Volume
15.97K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 221.95K | 336.25% |
Operating expense | 707.42K | 0.92% |
Net income | -217.81K | 69.57% |
Net profit margin | -98.14 | 93.03% |
Earnings per share | — | — |
EBITDA | -558.91K | 15.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 50.24K | -70.48% |
Total assets | 800.28K | -26.32% |
Total liabilities | 7.26M | 34.85% |
Total equity | -6.45M | — |
Shares outstanding | 132.63M | — |
Price to book | -0.01 | — |
Return on assets | -168.96% | — |
Return on capital | -587.82% | — |
Cash Flow
Net change in cash
| (CAD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -217.81K | 69.57% |
Cash from operations | -79.46K | 91.19% |
Cash from investing | 44.85K | — |
Cash from financing | 59.44K | -93.81% |
Net change in cash | 24.84K | -57.31% |
Free cash flow | -197.06K | 69.58% |
About
Founded
2013
Headquarters
Website
Employees
12
